NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

If I were a short, which I never am….


I would concern myself with the national and international news that will flow from these PRs.

In other words, we've had a Press Release, now we are due for a mainstream Press Reaction. Analyst upgrades are probably being considered as we post. These things are important for the company because more warrants and options are exercised as the price increases thus reducing the need for financing prior to ASCO in May. After ASCO, any fund raising will have a minimal effect on the price per share. This is good for investors and patients because it means that production capacity and trial completion are no longer mired by any funding issues whatsoever.

The crescendo stands at mezzo-forte thus far. Just wait until Ode to Joy and the 1812 Overture.